vs
Side-by-side financial comparison of Civeo Corp (CVEO) and HARROW, INC. (HROW). Click either name above to swap in a different company.
Civeo Corp is the larger business by last-quarter revenue ($161.6M vs $89.1M, roughly 1.8× HARROW, INC.). HARROW, INC. runs the higher net margin — 7.4% vs -4.0%, a 11.4% gap on every dollar of revenue. On growth, HARROW, INC. posted the faster year-over-year revenue change (33.3% vs 7.1%). Civeo Corp produced more free cash flow last quarter ($14.5M vs $8.1M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs -1.4%).
The Civeo Corporation is an American accommodation services multinational corporation. It is a spin-off of Oil States International. It is a public company listed on the New York Stock Exchange.
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
CVEO vs HROW — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $161.6M | $89.1M |
| Net Profit | $-6.5M | $6.6M |
| Gross Margin | 22.7% | 79.3% |
| Operating Margin | -0.1% | 17.5% |
| Net Margin | -4.0% | 7.4% |
| Revenue YoY | 7.1% | 33.3% |
| Net Profit YoY | 58.1% | -2.2% |
| EPS (diluted) | $-0.58 | $0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $161.6M | $89.1M | ||
| Q3 25 | $170.5M | $71.6M | ||
| Q2 25 | $162.7M | $63.7M | ||
| Q1 25 | $144.0M | $47.8M | ||
| Q4 24 | $151.0M | $66.8M | ||
| Q3 24 | $176.3M | $49.3M | ||
| Q2 24 | $188.7M | $48.9M | ||
| Q1 24 | $166.1M | $34.6M |
| Q4 25 | $-6.5M | $6.6M | ||
| Q3 25 | $-455.0K | $1.0M | ||
| Q2 25 | $-3.3M | $5.0M | ||
| Q1 25 | $-9.8M | $-17.8M | ||
| Q4 24 | $-15.4M | $6.8M | ||
| Q3 24 | $-5.1M | $-4.2M | ||
| Q2 24 | $8.2M | $-6.5M | ||
| Q1 24 | $-5.1M | $-13.6M |
| Q4 25 | 22.7% | 79.3% | ||
| Q3 25 | 25.7% | 75.3% | ||
| Q2 25 | 25.3% | 74.5% | ||
| Q1 25 | 20.4% | 67.5% | ||
| Q4 24 | 18.6% | 78.8% | ||
| Q3 24 | 21.4% | 75.6% | ||
| Q2 24 | 25.4% | 74.4% | ||
| Q1 24 | 21.5% | 69.5% |
| Q4 25 | -0.1% | 17.5% | ||
| Q3 25 | 4.1% | 20.6% | ||
| Q2 25 | 1.7% | 17.9% | ||
| Q1 25 | -3.8% | -23.5% | ||
| Q4 24 | -6.7% | 19.3% | ||
| Q3 24 | 0.0% | 2.7% | ||
| Q2 24 | 6.9% | 3.1% | ||
| Q1 24 | -1.1% | -20.0% |
| Q4 25 | -4.0% | 7.4% | ||
| Q3 25 | -0.3% | 1.4% | ||
| Q2 25 | -2.0% | 7.8% | ||
| Q1 25 | -6.8% | -37.2% | ||
| Q4 24 | -10.2% | 10.1% | ||
| Q3 24 | -2.9% | -8.6% | ||
| Q2 24 | 4.4% | -13.2% | ||
| Q1 24 | -3.1% | -39.2% |
| Q4 25 | $-0.58 | $0.20 | ||
| Q3 25 | $-0.04 | $0.03 | ||
| Q2 25 | $-0.25 | $0.13 | ||
| Q1 25 | $-0.72 | $-0.50 | ||
| Q4 24 | $-1.04 | $0.19 | ||
| Q3 24 | $-0.36 | $-0.12 | ||
| Q2 24 | $0.56 | $-0.18 | ||
| Q1 24 | $-0.35 | $-0.38 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $14.4M | $72.9M |
| Total DebtLower is stronger | — | $250.0M |
| Stockholders' EquityBook value | $174.4M | $52.4M |
| Total Assets | $477.4M | $399.5M |
| Debt / EquityLower = less leverage | — | 4.77× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.4M | $72.9M | ||
| Q3 25 | $12.0M | $74.3M | ||
| Q2 25 | $14.6M | $53.0M | ||
| Q1 25 | $28.4M | $66.7M | ||
| Q4 24 | $5.2M | $47.2M | ||
| Q3 24 | $17.9M | $72.6M | ||
| Q2 24 | $7.4M | $71.0M | ||
| Q1 24 | $16.8M | $76.0M |
| Q4 25 | — | $250.0M | ||
| Q3 25 | — | $347.2M | ||
| Q2 25 | — | $250.6M | ||
| Q1 25 | — | $256.9M | ||
| Q4 24 | $43.3M | $262.7M | ||
| Q3 24 | — | $230.7M | ||
| Q2 24 | — | $236.3M | ||
| Q1 24 | — | $243.4M |
| Q4 25 | $174.4M | $52.4M | ||
| Q3 25 | $182.5M | $47.0M | ||
| Q2 25 | $209.4M | $49.7M | ||
| Q1 25 | $220.7M | $56.5M | ||
| Q4 24 | $236.4M | $69.7M | ||
| Q3 24 | $282.2M | $58.0M | ||
| Q2 24 | $297.4M | $58.5M | ||
| Q1 24 | $297.4M | $60.6M |
| Q4 25 | $477.4M | $399.5M | ||
| Q3 25 | $491.1M | $363.1M | ||
| Q2 25 | $508.8M | $345.0M | ||
| Q1 25 | $423.8M | $364.2M | ||
| Q4 24 | $405.1M | $389.0M | ||
| Q3 24 | $477.6M | $351.5M | ||
| Q2 24 | $483.2M | $306.6M | ||
| Q1 24 | $513.1M | $295.5M |
| Q4 25 | — | 4.77× | ||
| Q3 25 | — | 7.39× | ||
| Q2 25 | — | 5.05× | ||
| Q1 25 | — | 4.55× | ||
| Q4 24 | 0.18× | 3.77× | ||
| Q3 24 | — | 3.98× | ||
| Q2 24 | — | 4.04× | ||
| Q1 24 | — | 4.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $19.3M | $8.4M |
| Free Cash FlowOCF − Capex | $14.5M | $8.1M |
| FCF MarginFCF / Revenue | 8.9% | 9.1% |
| Capex IntensityCapex / Revenue | 3.0% | 0.4% |
| Cash ConversionOCF / Net Profit | — | 1.27× |
| TTM Free Cash FlowTrailing 4 quarters | $2.1M | $43.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.3M | $8.4M | ||
| Q3 25 | $13.8M | $16.6M | ||
| Q2 25 | $-2.3M | $-803.0K | ||
| Q1 25 | $-8.4M | $19.7M | ||
| Q4 24 | $9.5M | $-17.8M | ||
| Q3 24 | $35.7M | $3.0M | ||
| Q2 24 | $32.4M | $-2.7M | ||
| Q1 24 | $6.0M | $-4.6M |
| Q4 25 | $14.5M | $8.1M | ||
| Q3 25 | $8.2M | $16.4M | ||
| Q2 25 | $-6.8M | $-969.0K | ||
| Q1 25 | $-13.7M | $19.5M | ||
| Q4 24 | $1.8M | $-18.3M | ||
| Q3 24 | $28.2M | $2.3M | ||
| Q2 24 | $27.0M | $-3.1M | ||
| Q1 24 | $372.0K | $-4.7M |
| Q4 25 | 8.9% | 9.1% | ||
| Q3 25 | 4.8% | 22.9% | ||
| Q2 25 | -4.2% | -1.5% | ||
| Q1 25 | -9.5% | 40.8% | ||
| Q4 24 | 1.2% | -27.4% | ||
| Q3 24 | 16.0% | 4.8% | ||
| Q2 24 | 14.3% | -6.3% | ||
| Q1 24 | 0.2% | -13.6% |
| Q4 25 | 3.0% | 0.4% | ||
| Q3 25 | 3.3% | 0.3% | ||
| Q2 25 | 2.8% | 0.3% | ||
| Q1 25 | 3.7% | 0.4% | ||
| Q4 24 | 5.1% | 0.8% | ||
| Q3 24 | 4.2% | 1.2% | ||
| Q2 24 | 2.8% | 0.7% | ||
| Q1 24 | 3.4% | 0.3% |
| Q4 25 | — | 1.27× | ||
| Q3 25 | — | 16.26× | ||
| Q2 25 | — | -0.16× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -2.62× | ||
| Q3 24 | — | — | ||
| Q2 24 | 3.93× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
